Invesco
KYMR icon

Invesco’s Kymera Therapeutics KYMR Stock Holding History

Invesco’s Portfolio KYMR Stock Details KYMR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.2M Sell
110,415
-6,332
-5% -$501K ﹤0.01% 1877
2025
Q4 		$9.08M Buy
116,747
+36,940
+46% +$2.49M ﹤0.01% 1907
2025
Q3 		$4.52M Buy
79,807
+31,923
+67% +$1.44M ﹤0.01% 2274
2025
Q2 		$2.09M Buy
47,884
+5,809
+14% +$200K ﹤0.01% 2563
2025
Q1 		$1.15M Buy
42,075
+11,343
+37% +$413K ﹤0.01% 2774
2024
Q4 		$1.24M Sell
30,732
-133,187
-81% -$6.02M ﹤0.01% 2829
2024
Q3 		$7.76M Buy
163,919
+134,085
+449% +$5.92M ﹤0.01% 1979
2024
Q2 		$891K Sell
29,834
-83,533
-74% -$2.89M ﹤0.01% 2992
2024
Q1 		$4.56M Buy
113,367
+85,278
+304% +$3.05M ﹤0.01% 2294
2023
Q4 		$715K Sell
28,089
-8,538
-23% -$153K ﹤0.01% 3040
2023
Q3 		$509K Buy
36,627
+6,197
+20% +$125K ﹤0.01% 3196
2023
Q2 		$700K Sell
30,430
-159,056
-84% -$4.56M ﹤0.01% 3068
2023
Q1 		$5.61M Buy
189,486
+175,993
+1,304% +$5.68M ﹤0.01% 2163
2022
Q4 		$337K Sell
13,493
-3
-0% -$80 ﹤0.01% 3458
2022
Q3 		$294K Sell
13,496
-67
-0.5% -$1.77K ﹤0.01% 3526
2022
Q2 		$267K Sell
13,563
-1,808
-12% -$42.2K ﹤0.01% 3616
2022
Q1 		$650K Buy
15,371
+146
+1% +$6.17K ﹤0.01% 3271
2021
Q4 		$967K Sell
15,225
-171
-1% -$9.96K ﹤0.01% 3077
2021
Q3 		$904K Buy
15,396
+6,132
+66% +$356K ﹤0.01% 3152
2021
Q2 		$450K Buy
+9,264
New +$402K ﹤0.01% 3462

Other funds holding KYMR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return